Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypercalcemia, arrhythmia, and mood stabilizers.

M E Wolf1, V Ranade, J Molnar

  • 1Mental Health Services, VA Medical Center, North Chicago, Illinois 60064, USA.

Journal of Clinical Psychopharmacology
|April 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrix metalloproteinase profile in patients with Creuztfeldt-Jakob disease.

International journal of clinical practice·2003
Same author

Structural and functional diversity of lysyl oxidase and the LOX-like proteins.

Biochimica et biophysica acta·2003
Same author

Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries.

Placenta·2003
Same author

Antioxidative activity of Allium victorialis L. extracts.

Anticancer research·2002
Same author

Study on the hypothalamic factors mediating the inhibitory effect of PACAP38 on ovulation.

Peptides·2002
Same author

Monitoring of MRP-like activity in human erythrocytes: inhibitory effect of isoflavones.

Blood cells, molecules & diseases·2002
Same journal

Are the 8 Finnish Deaths Explained by Agranulocytosis More Important than the Thousands of Suicide Deaths Associated with the Lack of Use of Clozapine? Reflections on Clozaphobia.

Journal of clinical psychopharmacology·2026
Same journal

Aripiprazole Withdrawal-Associated Restless Legs Syndrome During Clozapine Treatment in an Adolescent With Schizoaffective Disorder: A Case Report.

Journal of clinical psychopharmacology·2026
Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026
Same journal

Article Selected to Receive the Mitchell B. Balter Award for Publications in 2025.

Journal of clinical psychopharmacology·2026
Same journal

Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.

Journal of clinical psychopharmacology·2026
Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026
See all related articles

Lithium therapy in bipolar patients can cause hypercalcemia and bradyarrhythmia. This study found lithium-associated hypercalcemia increases the risk of conduction defects, highlighting the need for careful monitoring.

Area of Science:

  • Psychiatry
  • Cardiology
  • Endocrinology

Background:

  • Lithium is a mood stabilizer for bipolar disorder.
  • Hypercalcemia and bradyarrhythmia are potential adverse effects of lithium therapy.
  • A case report prompted investigation into lithium-associated hypercalcemia.

Purpose of the Study:

  • To investigate the cardiac effects of lithium-associated hypercalcemia in bipolar patients.
  • To compare electrocardiographic findings in patients with lithium-associated hypercalcemia to control groups.

Main Methods:

  • Retrospective study of bipolar patients with and without hypercalcemia.
  • Comparison of electrocardiographic (ECG) findings between lithium-treated hypercalcemic patients and normocalcemic controls (lithium-treated and anticonvulsant-treated).

Related Experiment Videos

  • Inclusion of patients with hypercalcemia from other medical conditions for comparison.

    • Main Results:

    • No significant difference in overall ECG abnormalities between groups.
    • Significantly higher frequency of conduction defects in lithium-associated hypercalcemia and other hypercalcemia groups.
    • No mortality in lithium-associated hypercalcemia or control groups, versus 28% in medically ill hypercalcemic patients.

    Conclusions:

    • Lithium-associated hypercalcemia is linked to an increased risk of cardiac conduction defects.
    • Careful cardiac monitoring is essential for bipolar patients on lithium therapy, especially those with hypercalcemia.
    • Hypercalcemia from other medical conditions carries a high mortality risk.